Is this you?
Request access for CenExel Clinical Research with your @cenexelresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
CenExel Clinical Research
Unclaimed profileSMO · Salt Lake City, UT · ~18 sites
Intera lens
ICP 8Lift (cardio sample) 0.30Recruit soph 0.29
Quality Scorecard (1–100)
Overall68Recruit64Ops70Sponsor71Ther66
Performance (observed)
Historical trials
227
Completed
96
Terminated/Withdrawn
16
Completion rate
86%
Active now
114
Phase 2
107
Phase 3
94
Realized enrollment
291,323
First study year
2012
Years active
14
Match confidence
high
Enrollment velocity (inf)
20,809
Therapeutic
Areas
CNS, early-phase, pain, metabolic/endocrine (obesity, T2D), vaccines, complex neurology
Specialties
Early-phase; First-in-Human, Psychedelics, SAD/MAD studies
Breadth (conditions)
157
Languages
English + Spanish (detected)
States
AZ, CA, CO, FL, GA, MD, NJ, UT
Recruitment (web observed)
Patient database
Y; CenExel Clinical Trials App for participant recruitment
Advertises recruitment
Yes
SEO
Moderate; patient app and early-phase specialty focus
Capability notes
Patient-centric approach; 600+ bed capacity; consistently exceeds 100% enrollment targets; advanced recruitment strategies; participant-focused programs
Relationships
Sponsors
ModernaTX, Inc.; Eli Lilly and Company; Hoffmann-La Roche; Sanofi Pasteur, a Sanofi Company; AbbVie; Pfizer
CROs
Allucent; Premier Research; Worldwide Clinical Trials
Owner / parent
BayPine LP (majority); Webster Equity (minority)
Acquisitions
None identified
Expansion
360,000+ sq ft footprint; 600+ beds; multiple U.S. locations
Capacity & people
Investigators
—
Coordinators
—
CEO
Sy Pretorius (as of May 2026)
VP Clinical Ops
Patrick McLaughlin (Chief Operating Officer)
VP Site Ops
Unknown
VP Recruitment
Cindi Heckmann (VP, Patient Recruitment and Engagement)
Emails
Unknown
Tech & DCT
eSource
Yes
Builds tech
Vendors + proprietary apps (CenExel Trials App)
DCT / decentralized
Unknown; patient-centric recruitment mentioned
Tech stack
CenExel Trials App (patient engagement platform); advanced data analytics
Recruiting visible
Y
Notes
Strong Intera fit: 18-site network, 600+ beds, specializes in high-enrollment areas (early-phase, CNS, metabolic). Active recruitment with patient-focused engagement apps. Multiple concurrent recruiting studies evident. Demonstrates recruitment capability and scale. Well-capitalized with growth trajectory. [Validated: 3 active recruiting cardiometabolic trials on ClinicalTrials.gov.]
Recommendation features (sample indication)
Ind fit 0.42Liftability 0.30Overall68
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.